nach oben

Erschienen in:

01.05.2012 | Review Article

Medication-Related Falls in the Elderly

Causative Factors and Preventive Strategies

verfasst von: Dr Allen R. Huang, MDCM, FRCP, FACP, AGSF, Louise Mallet, Christian M. Rochefort, Tewodros Eguale, David L. Buckeridge, Robyn Tamblyn

Erschienen in: Drugs & Aging | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

People are living to older age. Falls constitute a leading cause of injuries, hospitalization and deaths among the elderly. Older people fall more often for a variety of reasons: alterations in physiology and physical functioning, and the use (and misuse) of medications needed to manage their multiple conditions. Pharmacological factors that place the elderly at greater risk of drug-related side effects include changes in body composition, serum albumin, total body water, and hepatic and renal functioning. Drug use is one of the most modifiable risk factors for falls and falls-related injuries. Fall-risk increasing drugs (FRIDs) include drugs for cardiovascular diseases (such as digoxin, type 1a anti-arrhythmics and diuretics), benzodiazepines, antidepressants, antiepileptics, antipsychotics, antiparkinsonian drugs, opioids and urological spasmolytics. Psychotropic and benzodiazepine drug use is most consistently associated with falls. Despite the promise of a more favourable side-effect profile, evidence shows that atypical antipsychotic medications and selective serotonin reuptake inhibitor antidepressants do not reduce the risk of falls and hip fractures. Despite multiple efforts with regards to managing medication-associated falls, there is no clear evidence for an effective intervention. Stopping or lowering the dose of psychotropic drugs and benzodiazepines does work, but ensuring a patient remains off these drugs is a challenge. Computer-assisted alerts coupled with electronic prescribing tools are a promising approach to lowering the risk of falls as the use of information technologies expands within healthcare.

World Health organization (WHO). World Health Statistics 2011. Geneva: WHO Press, 2011

Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Natl Vital Stat Rep 1999; 47 (19): 1–104

Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994; 331 (13): 821–7PubMed

Hanlon JT, Landerman LR, Fillenbaum GG, et al. Falls in African American and White community-dwelling elderly residents. J Gerontol A Biol Sci Med Sci 2002; 57 (7): M473–8PubMed

Zecevic AA, Salmoni AW, Speechley M, et al. Defining a fall and reasons for falling: comparisons among the views of seniors, health care providers, and the research literature. Gerontologist 2006; 46 (3): 367–76PubMed

Violence and injury prevention: other injury topics: falls. Geneva: WHO [online]. Available from URL: http://www.who.int/violence_injury_prevention/other_injury/falls/en/index.html [Accessed 2012 Mar 26]

Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmac 2010; 8 (3): 215–24

Bjerrum L, Rosholm JU, Hallas J, et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997; 53 (1): 7–11PubMed

Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Can Med Assoc J 2003; 169 (6): 549–56

10.

Vestal RE. Aging and pharmacology. Cancer 1997; 80 (7): 1302–10PubMed

11.

Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet 1998; 35 (1): 49–64PubMed

12.

Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38 (8): 843–53PubMed

13.

Campion EW, Avorn J, Reder VA, et al. Overmedication of the low-weight elderly. Arch Intern Med 1987; 147 (5): 945–7PubMed

14.

Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmac 2004; 2 (4): 274–302

15.

Grenier L. Pharmacocinétique et pharmacodynamie. In: Mallet L, Grenier L, Guimond J, et al., editors. Manuel de soins pharmaceutiques en gériatrie. Quebec (QC): Les presses de l université Laval, 2003: 77–98

16.

Hutchison LC, O’Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract 2007; 20(1): 4–12

17.

Kinirons MT, O’Mahony MS. Drug metabolism and ageing. Br J Clin Pharmacol 2004; 57 (5): 540–4PubMed

18.

Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370 (9582): 185–91PubMed

19.

Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 2009; 4: 225–33PubMed

20.

Minzenberg MJ, Poole JH, Benton C, et al. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiat 2004; 161 (1): 116–24PubMed

21.

Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2006; 81 (2): 235–41PubMed

22.

Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2007; 83 (3): 422–9PubMed

23.

Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167 (8): 781–7PubMed

24.

Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011; 59 (5): 875–80PubMed

25.

Aizenberg D, Sigler M, Weizman A, et al. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr 2002; 14 (03): 307–10PubMed

26.

Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. Western J Med 1981; 135 (6): 434–40

27.

Dalstra JAA, Kunst AE, Borrell C, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005; 34 (2): 316–26PubMed

28.

Hogan DB, Ebly EM, Fung TS. Disease, disability, and age in cognitively intact seniors: results from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 1999; 54 (2): M77–82PubMed

29.

Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970–2002. JAMA 2005; 294 (10): 1255–9PubMed

30.

Scuffham P, Chaplin S, Legood R. Incidence and costs of unintentional falls in older people in the United Kingdom. J Epidemiol Commun H 2003; 57 (9): 740–4

31.

Public health and aging: nonfatal injuries among older adults treated in hospital emergency department: United States, 2001. MMWR Morb Mortal Wkly Rep 2003; 52 (42): 1019–22

32.

Rubenstein LZ, Josephson KR. The epidemiology of falls and syncope. Clin Geriatr Med 2002; 18 (2): 141–58PubMed

33.

Tinetti ME, Doucette J, Claus E, et al. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc 1995; 43 (11): 1214–21PubMed

34.

Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997; 337 (18): 1279–84PubMed

35.

Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995; 274 (1): 29–34PubMed

36.

Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. Can Med Assoc J 2004; 170 (11): 1678–86

37.

King MB, Tinetti ME. Falls in community-dwelling older persons. J Am Geriatr Soc 1995; 43 (10): 1146–54PubMed

38.

Hosseini H, Hosseini N. Epidemiology and prevention of fall injuries among the elderly. Hosp Top 2008; 86 (3): 15–20PubMed

39.

Guelich MM. Prevention of falls in the elderly: a literature review. Top Geriatr Rehabil 1999; 15 (1): 15–25

40.

Van der Velde N, Stricker BH, Pols HA, et al. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2007; 63 (2): 232–7PubMed

41.

Kragh A, Elmstahl S, Atroshi I. Older adults’ medication use 6 months before and after hip fracture: a population-based cohort study. J Am Geriatr Soc 2011; 59 (5): 863–8PubMed

42.

Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47 (1): 40–50PubMed

43.

Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47 (1): 30–9PubMed

44.

Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169 (21): 1952–60PubMed

45.

Bloch F, Thibaud M, Dugue B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011; 23 (2): 329–46PubMed

46.

Liu B, Anderson G, Mittmann N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351 (9112): 1303–7PubMed

47.

Nurminen J, Puustinen J, Piirtola M, et al. Psychotropic drugs and the risk of fractures in old age: a prospective population-based study. BMC Public Health 2010; 10: 396. doi:10.1186/1471-2458-10–396PubMed

48.

Moden B, Merlo J, Ohlsson H, et al. Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Commun H 2010; 64 (5): 440–6

49.

Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146 (11): 775–86PubMed

50.

Vitry AI, Hoile AP, Gilbert AL, et al. The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people. Arch Gerontol Geriatr 2010; 50 (3): e1–4PubMed

51.

Sullivan MD, Edlund MJ, Fan MY, et al. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008; 138 (2): 440–9PubMed

52.

Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 2000; 162 (2): 225–33

53.

Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med 2006; 260 (1): 76–87PubMed

54.

Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002; 50 (10): 1629–37PubMed

55.

Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262 (23): 3303–7PubMed

56.

Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000; 53 (12): 1222–9PubMed

57.

Herings RMC, Stricker BHC, De BA, et al. Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Arch Intern Med 1995; 155 (16): 1801–7PubMed

58.

Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing residents home. J Am Geriatr Soc 2000; 48 (6): 682–5PubMed

59.

Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11 (2): 97–104PubMed

60.

Tamblyn R, Abrahamowicz M, Du BR, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53 (2): 233–41PubMed

61.

Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr 2010; 22 (3): 346–72PubMed

62.

Hien le TT, Cumming RG, Cameron ID, et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc 2005; 53 (8): 1290–5

63.

Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs Aging 2010; 27 (10): 815–29PubMed

64.

Liperoti R, Onder G, Lapane KL, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiat 2007; 68 (6): 929–34

65.

Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339 (13): 875–82PubMed

66.

Arfken CL, Wilson JG, Aronson SM. Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents. Int Psychogeriatr 2001; 13 (1): 86–91

67.

Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Br Med J 2011 Aug 2; 343: d4551. doi:10.1136/bmj.d4551

68.

Mallet L. Les anticonvulsivants. In: Mallet L, Grenier L, Guimond J, et al., editors. Quebec (QC): Les Presses de l université Laval, 2003: 223–44

69.

Kelly KD, Pickett W, Yiannakoulas N, et al. Medication use and falls in community-dwelling older persons. Age Ageing 2003; 32 (5): 503–9PubMed

70.

Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcified Tissue Int 2007; 81 (3): 153–61

71.

Kim DH, Brown RT, Ding EL, et al. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc 2011; 59 (6): 1019–31PubMed

72.

Takkouche B, Montes-Martinez A, Gill SS, et al. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007; 30 (2): 171–84PubMed

73.

Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 1998; 148 (9): 887–92PubMed

74.

Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003; 163 (8): 949–57PubMed

75.

Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2009; 64 (4): 492–8PubMed

76.

Buckeridge D, Huang A, Hanley J, et al. Risk of Injury associated with opioid use in older adults. J Am Geriatr Soc 2010; 58 (9): 1664–70PubMed

77.

Koski K, Luukinen H, Laippala P, et al. Physiological factors and medications as predictors of injurious falls by elderly people: a prospective population-based study. Age Ageing 1996; 25 (1): 29–38PubMed

78.

Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc 2007; 55 (12): 2041–4PubMed

79.

Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358 (24): 2545–59

80.

Malmivaara A, Heliovaara M, Knekt P, et al. Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol 1993; 138 (6): 384–94PubMed

81.

Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and benzodiazepines in falls: an epidemiological view. Drug Alcohol Depen 2005; 79 (2): 225–30

82.

Onen SH, Onen F, Mangeon JP, et al. Alcohol abuse and dependence in elderly emergency department patients. Arch Gerontol Geriat 2005; 41 (2): 191–200

83.

Baker SP, Haddon Jr W. Reducing injuries and their results: the scientific approach. Milbank Q 1974; 52 (4): 377–89

84.

Haddon J. Options for the prevention of motor vehicle crash injury. Israel J Med Sci 1980; 16 (1): 45–65PubMed

85.

Haddon Jr W. On the escape of tigers: an ecologic note. Am J Public Health N 1970; 60 (12): 2229–34

86.

Runyan CW. Using the Haddon matrix: introducing the third dimension. Injury Prev 1998; 4 (4): 302–7

87.

Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151 (9): 1825–32PubMed

88.

Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531–6PubMed

89.

Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163 (22): 2716–24PubMed

90.

McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997; 156 (3): 385–91

91.

The American Geriatrics Society. American geriatrics society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60 (4): 616–31

92.

Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 2009; 9: 30. doi:10.1186/1471-2318-9–30PubMed

93.

Gallagher P, Baeyens JP, Topinkova E, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009; 38 (5): 603–6PubMed

94.

Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008; 37 (6): 673–9PubMed

95.

Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation. Int J Clin Pharm Ther 2008; 46 (2): 72–83

96.

Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89 (6): 845–54PubMed

97.

Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171 (11): 1013–9PubMed

98.

Pyszka LL, Seys Ranola TM, Milhans SM. Identification of inappropriate prescribing in geriatrics at a Veterans Affairs hospital using STOPP/START screening tools. Consult Pharm 2010; 25 (6): 365–73PubMed

99.

Pugh MJ, Hanlon JT, Wang CP, et al. Trends in use of high-risk medications for older veterans: 2004 to 2006. J Am Geriatr Soc 2011; 59 (10): 1891–8PubMed

100.

Tinetti ME, Baker DI, King M, et al. Effect of dissemination of evidence in reducing injuries from falls. N Engl J Med 2008; 359 (3): 252–61PubMed

101.

Rubenstein LZ, Powers CM, MacLean CH. Quality indicators for the management and prevention of falls and mobility problems in vulnerable elders. Ann Intern Med 2001; 135 (8 Pt 2): 686–93PubMed

102.

Chang JT, Ganz DA. Quality indicators for falls and mobility problems in vulnerable elders. J Am Geriatr Soc 2007; 55 Suppl.: S327–34PubMed

103.

Chang JT, Morton SC, Rubenstein LZ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004; 328 (7441): 680PubMed

104.

Shaw FE, Bond J, Richardson DA, et al. Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial. BMJ 2003; 326 (7380): 73PubMed

105.

Coussement J, De PL, Schwendimann R, et al. Interventions for preventing falls in acute- and chronic-care hospitals: a systematic review and meta-analysis. J Am Geriatr Soc 2008; 56 (1): 29–36PubMed

106.

Cumming RG, Sherrington C, Lord SR, et al. Cluster randomised trial of a targeted multifactorial intervention to prevent falls among older people in hospital. BMJ 2008; 336

107.

Van der Velde N, Meerding WJ, Looman CW, et al. Cost effectiveness of withdrawal of fall-risk-increasing drugs in geriatric outpatients. Drugs Aging 2008; 25 (6): 521–9PubMed

108.

Van der Velde N, Stricker BH, Pols HA, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24 (8): 691–9PubMed

109.

Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47 (7): 850–3PubMed

110.

Hartholt K, Van der Velde N, Van Lieshout E, et al. [Cost]effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study). BMC Geriatr 2011; 11 (1): 48. doi:10.1186/1471-2318-11–48PubMed

111.

Joester J, Vogler CM, Chang K, et al. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Drugs Aging 2010; 27 (11): 915–24PubMed

112.

Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23 (1): 19–34PubMed

113.

Salonoja M, Salminen M, Aarnio P, et al. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing 2010; 39 (3): 313–9PubMed

114.

Smith AJ, Tett SE. Improving the use of benzodiazepines: is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res 2010; 10: 321PubMed

115.

Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA 2009; 301 (8): 865–7PubMed

116.

Schiff GD, Rucker TD. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA 1998; 279 (13): 1024–9PubMed

117.

Schnipper JL. Medication safety: are we there yet? Comment on “Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients”. Arch Intern Med 2011; 171 (11): 1019–20PubMed

118.

Agostini JV, Zhang Y, Inouye SK. Use of a computer-based reminder to improve sedative-hypnotic prescribing in older hospitalized patients. J Am Geriatr Soc 2007; 55 (1): 43–8PubMed

119.

Ball MJ, Lillis J. E-health: transforming the physician/patient relationship. Int J Med Inform 2001; 61 (1): 1–10PubMed

120.

Dickerson S, Reinhart AM, Feeley TH, et al. Patient internet use for health information at three urban primary care clinics. J Am Med Inform Assoc 2004; 11 (6): 499–504PubMed

121.

Weingart SN, Toth M, Sands DZ, et al. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med 2003; 163 (21): 2625–31PubMed

122.

Tamblyn R, Huang A, Taylor L, et al. A randomized trial of the effectiveness of on-demand versus computer-triggered drug decision support in primary care. J Am Med Inform Assoc 2008; 15 (4): 430–8PubMed

123.

van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13 (2): 138–47PubMed

124.

Julien M, Hanley JA. Profile-specific survival estimates: making reports of clinical trials more patient-relevant. Clin Trials 2008; 5 (2): 107–15PubMed

125.

Tamblyn RM, Eguale T, Buckeridge D, et al. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial. J Am Med Inform Assoc. Epub 2012 Jan 12. doi:10.1136/amiajnl-2011–000609

126.

Hill S, Spink J, Cadilhac D, et al. Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health 2010; 10: 108PubMed

127.

Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002; 324 (7341): 827–30PubMed

128.

Tzeng HM, Yin CY, Grunawalt J. Effective assessment of use of sitters by nurses in inpatient care settings. J Adv Nurs 2008; 64 (2): 176–83PubMed

129.

Jaworowski S, Raveh D, Lobel E, et al. Constant observation in the general hospital: a review. Isr J Psychiatr Rel 2008; 45 (4): 278–84

130.

Rausch DL, Bjorklund P. Decreasing the costs of constant observation. J Nurs Admin 2010; 40 (2): 75–81

131.

Donoghue J, Graham J, Mitten-Lewis S, et al. A volunteer companion-observer intervention reduces falls on an acute aged care ward. Int J Health Care Qual Assur Inc Leadersh Health Serv 2005; 18 (1): 24–31PubMed

132.

Worley LL, Kunkel EJ, Gitlin DF, et al. Constant observation practices in the general hospital setting: a national survey. Psychosomatics 2000; 41 (4): 301–10PubMed

133.

Torkelson DJ, Dobal MT. Constant observation in medical-surgical settings: a multihospital study. Nurs Econ 1999; 17 (3): 149–55PubMed

134.

Rochefort CM, Ward L, Ritchie JA, et al. Registered nurses’ job demands in relation to sitter use: nested case-control study. Nurs Res 2011; 60 (4): 221–30PubMed

135.

Rochefort CM, Ward L, Ritchie JA, et al. Patient and nurse staffing characteristics associated with high sitter use costs. J Adv Nurs. Epub 2011 Nov 3. doi:10.1111/j.1365–2648.2011.05864.x

136.

Charbonneau-Allard A-M, Fluet J, Lessard A, et al. Mécanismes pharmacologiques comme facteurs modifiables de la prescription de sitters. 2011. Montréal (QC): Faculte de pharmacie, Université de Montréal, 2011

Titel: Medication-Related Falls in the Elderly
Causative Factors and Preventive Strategies
verfasst von: Dr Allen R. Huang, MDCM, FRCP, FACP, AGSF
Louise Mallet
Christian M. Rochefort
Tewodros Eguale
David L. Buckeridge
Robyn Tamblyn
Publikationsdatum: 01.05.2012
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 5/2012
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/11599460-000000000-00000

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Medication-Related Falls in the Elderly

Causative Factors and Preventive Strategies

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Erratum to: Abiraterone acetate: a guide to its use in metastatic castration-resistant prostate cancer

Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes

Does Lithium Prevent Alzheimer’s Disease?

Drug Burden Index and Hospitalization among Community-Dwelling Older People

Impact of Revisions to the F-Tag 309 Surveyors’ Interpretive Guidelines on Pain Management among Nursing Home Residents

Dutasteride/Tamsulosin

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Update Innere Medizin